Cardiac Resynchronisation Therapy Market 2025 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Cardiac Resynchronisation Therapy Market to 2025 - Global Analysis and Forecasts By Product [CRT-Defibrillator (CRT-D), CRT-Pacemaker (CRT-P)], End user (Hospitals, Ambulatory Surgical Centers, Others) and Geography

Report Code: TIPMD00002385 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
Cardiac Resynchronisation Therapy (CRT) is the insertion of electrodes in the left and right ventricles of the heart, as well as on occasion the right atrium, to treat heart failure by coordinating the function of the left and right ventricles. Cardiac resynchronization therapy is used to treat heart diseases. Irregular heartbeats is known as arrhythmias that can be caused due to the various reasons such as age, damage of heart, genetic factors and so far used medications. CRT, or biventricular pacing, is used to improve the rhythm of the heart and reduce the symptoms that are associated with the arrhythmias in the heart failure patients.

The cardiac resynchronisation therapy market is anticipated to grow at a significant rate in the coming years, owing to factors such as, increase in prevalence rate of the heart diseases, rise in the demand of the invasive techniques in treatment of the heart diseases and changes in the life style, Moreover, advancements in the technologies and rise in the adaptability of the CRT devices are fuelling the market of the CRT devices. Various technological developments in the healthcare industry in Asia Pacific are expected to offer growth opportunities for the players operating in the cardiac resynchronisation therapy market.

The "Global Cardiac Resynchronisation Therapy Market Analysis to 2025" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global cardiac resynchronisation therapy market with detailed market segmentation by product and end user. The global cardiac resynchronisation therapy market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the cardiac resynchronisation therapy market.

The global cardiac resynchronisation therapy market is segmented on the basis of product and end user. The product segment of cardiac resynchronisation therapy market includes, CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P). Based on end user, the cardiac resynchronisation therapy market is segmented as, hospitals, ambulatory surgical centers, and others.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global cardiac resynchronisation therapy market based on product and end user. It also provides market size and forecast till 2025 for overall cardiac resynchronisation therapy market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The cardiac resynchronisation therapy market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

North America is expected to contribute to the largest share in the cardiac resynchronisation therapy market in the coming years, owing to factors such as, prevalence rates of heart diseases, well established healthcare infrastructure and increase in adaptability rates of CRT devices. Asia Pacific is expected to witness significant growth rate owing to rapid expansion of industry players within these regions in terms of manufacturing as well as distribution, in addition increased adaptability rates of a CRT devices and increase in awareness regarding CRT devices.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The report also includes the profiles of key cardiac resynchronisation therapy manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Medtronic, Abbott, Boston Scientific Corporation, BIOTRONIK, LivaNova PLC, Merit Medical Systems, NIHON KOHDEN CORPORATION, Koninklijke Philips N.V., Lepu Medical Technology Co. Ltd., and Japan Lifeline Co., Ltd. among others.
Table of Contents

1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

2. KEY TAKEAWAYS

3. CARDIAC RESYNCHRONISATION THERAPY MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Cardiac Resynchronisation Therapy market - By Product
3.2.2. Cardiac Resynchronisation Therapy market - By End User
3.2.3. Cardiac Resynchronisation Therapy market - By Region
3.2.3.1. By Country

4. CARDIAC RESYNCHRONISATION THERAPY MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS

5. CARDIAC RESYNCHRONISATION THERAPY MARKET - GLOBAL ANALYSIS
5.1. GLOBAL CARDIAC RESYNCHRONISATION THERAPY MARKET OVERVIEW
5.2. GLOBAL CARDIAC RESYNCHRONISATION THERAPY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. PERFORMANCE OF KEY PLAYERS
5.4. EXPERT OPINIONS

6. CARDIAC RESYNCHRONISATION THERAPY MARKET REVENUE AND FORECASTS TO 2025 - BY PRODUCT
6.1. OVERVIEW
6.2. PRODUCT MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. CRT-DEFIBRILLATOR (CRT-D) MARKET
6.3.1. Overview
6.3.2. CRT-Defibrillator (CRT-D) Market Revenue Forecasts and Analysis (US$ Mn)
6.4. CRT-PACEMAKER (CRT-P) MARKET
6.4.1. Overview
6.4.2. CRT-Pacemaker (CRT-P) Market Revenue Forecasts and Analysis (US$ Mn)

7. CARDIAC RESYNCHRONISATION THERAPY MARKET REVENUE AND FORECASTS TO 2025 - BY END USER
7.1. OVERVIEW
7.2. END USER MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. HOSPITALS MARKET
7.3.1. Overview
7.3.2. Hospitals Market Revenue Forecasts and Analysis (US$ Mn)
7.4. AMBULATORY SURGICAL CENTERS MARKET
7.4.1. Overview
7.4.2. Ambulatory Surgical Centers Market Revenue Forecasts and Analysis (US$ Mn)
7.5. OTHERS MARKET
7.5.1. Overview
7.5.2. Others Market Revenue Forecasts and Analysis (US$ Mn)

8. NORTH AMERICA CARDIAC RESYNCHRONISATION THERAPY MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
8.1. NORTH AMERICA CARDIAC RESYNCHRONISATION THERAPY MARKET OVERVIEW
8.2. NORTH AMERICA CARDIAC RESYNCHRONISATION THERAPY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
8.3. NORTH AMERICA CARDIAC RESYNCHRONISATION THERAPY MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT(US$ MN)
28.4. NORTH AMERICA CARDIAC RESYNCHRONISATION THERAPY MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
8.5. NORTH AMERICA CARDIAC RESYNCHRONISATION THERAPY MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
8.6. US MARKET OVERVIEW
8.6.1. US Cardiac Resynchronisation Therapy Market Revenue Forecasts and Analysis - By Product(US$ Mn)
8.6.2. US Cardiac Resynchronisation Therapy Market Revenue Forecasts and Analysis - By End User (US$ Mn)
8.7. CANADA MARKET OVERVIEW
8.7.1. Canada Cardiac Resynchronisation Therapy Market Revenue Forecasts and Analysis - By Product(US$ Mn)
8.7.2. Canada Cardiac Resynchronisation Therapy Market Revenue Forecasts and Analysis - By End User (US$ Mn)
8.8. MEXICO MARKET OVERVIEW
8.8.1. Mexico Cardiac Resynchronisation Therapy Market Revenue Forecasts and Analysis - By Product(US$ Mn)
8.8.2. Mexico Cardiac Resynchronisation Therapy Market Revenue Forecasts and Analysis - By End User (US$ Mn)

9. EUROPE CARDIAC RESYNCHRONISATION THERAPY MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
9.1. EUROPE CARDIAC RESYNCHRONISATION THERAPY MARKET OVERVIEW
9.2. EUROPE CARDIAC RESYNCHRONISATION THERAPY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. EUROPE CARDIAC RESYNCHRONISATION THERAPY MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT(US$ MN)
9.4. EUROPE CARDIAC RESYNCHRONISATION THERAPY MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
9.5. FRANCE MARKET OVERVIEW
9.5.1. France Cardiac Resynchronisation Therapy Market Revenue Forecasts and Analysis - By Product(US$ Mn)
9.5.2. France Cardiac Resynchronisation Therapy Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.6. GERMANY MARKET OVERVIEW
9.6.1. Germany Cardiac Resynchronisation Therapy Market Revenue Forecasts and Analysis - By Product(US$ Mn)
9.6.2. Germany Cardiac Resynchronisation Therapy Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.7. UK MARKET OVERVIEW
9.7.1. UK Cardiac Resynchronisation Therapy Market Revenue Forecasts and Analysis - By Product(US$ Mn)
9.7.2. UK Cardiac Resynchronisation Therapy Market Revenue Forecasts and Analysis - By End User (US$ Mn)

10. ASIA PACIFIC CARDIAC RESYNCHRONISATION THERAPY MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
10.1. ASIA PACIFIC CARDIAC RESYNCHRONISATION THERAPY MARKET OVERVIEW
10.2. ASIA PACIFIC CARDIAC RESYNCHRONISATION THERAPY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. ASIA PACIFIC CARDIAC RESYNCHRONISATION THERAPY MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT(US$ MN)
10.4. ASIA PACIFIC CARDIAC RESYNCHRONISATION THERAPY MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
10.5. CHINA MARKET OVERVIEW
10.5.1. China Cardiac Resynchronisation Therapy Market Revenue Forecasts and Analysis - By Product(US$ Mn)
10.5.2. China Cardiac Resynchronisation Therapy Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.6. INDIA MARKET OVERVIEW
10.6.1. India Cardiac Resynchronisation Therapy Market Revenue Forecasts and Analysis - By Product(US$ Mn)
10.6.2. India Cardiac Resynchronisation Therapy Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.7. JAPAN MARKET OVERVIEW
10.7.1. Japan Cardiac Resynchronisation Therapy Market Revenue Forecasts and Analysis - By Product(US$ Mn)
10.7.2. Japan Cardiac Resynchronisation Therapy Market Revenue Forecasts and Analysis - By End User (US$ Mn)

11. MIDDLE EAST AND AFRICA (MEA) CARDIAC RESYNCHRONISATION THERAPY MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
11.1. MIDDLE EAST AND AFRICA (MEA) CARDIAC RESYNCHRONISATION THERAPY MARKET OVERVIEW
11.2. MIDDLE EAST AND AFRICA (MEA) CARDIAC RESYNCHRONISATION THERAPY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. MIDDLE EAST AND AFRICA (MEA) CARDIAC RESYNCHRONISATION THERAPY MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT(US$ MN)
11.4. MIDDLE EAST AND AFRICA (MEA) CARDIAC RESYNCHRONISATION THERAPY MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
?
11.5. SOUTH AFRICA MARKET OVERVIEW
11.5.1. South Africa Cardiac Resynchronisation Therapy Market Revenue Forecasts and Analysis - By Product(US$ Mn)
11.5.2. South Africa Cardiac Resynchronisation Therapy Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.6. SAUDI ARABIA MARKET OVERVIEW
11.6.1. Saudi Arabia Cardiac Resynchronisation Therapy Market Revenue Forecasts and Analysis - By Product(US$ Mn)
11.6.2. Saudi Arabia Cardiac Resynchronisation Therapy Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.7. UAE MARKET OVERVIEW
11.7.1. UAE Cardiac Resynchronisation Therapy Market Revenue Forecasts and Analysis - By Product(US$ Mn)
11.7.2. UAE Cardiac Resynchronisation Therapy Market Revenue Forecasts and Analysis - By End User (US$ Mn)

12. SOUTH AND CENTRAL AMERICA CARDIAC RESYNCHRONISATION THERAPY MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
12.1. SOUTH AND CENTRAL AMERICA CARDIAC RESYNCHRONISATION THERAPY MARKET OVERVIEW
12.2. SOUTH AND CENTRAL AMERICA CARDIAC RESYNCHRONISATION THERAPY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. SOUTH AND CENTRAL AMERICA CARDIAC RESYNCHRONISATION THERAPY MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT(US$ MN)
12.4. SOUTH AND CENTRAL AMERICA CARDIAC RESYNCHRONISATION THERAPY MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
12.5. BRAZIL MARKET OVERVIEW
12.5.1. Brazil Cardiac Resynchronisation Therapy Market Revenue Forecasts and Analysis - By Product(US$ Mn)
12.5.2. Brazil Cardiac Resynchronisation Therapy Market Revenue Forecasts and Analysis - By End User (US$ Mn)

13. CARDIAC RESYNCHRONISATION THERAPY MARKET, KEY COMPANY PROFILES
13.1. MEDTRONIC
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Financial Overview
13.1.4. Product Portfolio
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ABBOTT
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Financial Overview
13.2.4. Product Portfolio
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. BOSTON SCIENTIFIC CORPORATION
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Financial Overview
13.3.4. Product Portfolio
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. BIOTRONIK
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Financial Overview
13.4.4. Product Portfolio
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. LIVANOVA PLC
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Financial Overview
13.5.4. Product Portfolio
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. MERIT MEDICAL SYSTEMS
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Financial Overview
13.6.4. Product Portfolio
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. NIHON KOHDEN CORPORATION
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Financial Overview
13.7.4. Product Portfolio
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. KONINKLIJKE PHILIPS N.V.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Financial Overview
13.8.4. Product Portfolio
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. LEPU MEDICAL TECHNOLOGY CO. LTD.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Financial Overview
13.9.4. Product Portfolio
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. JAPAN LIFELINE CO., LTD.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Financial Overview
13.10.4. Product Portfolio
13.10.5. SWOT Analysis
13.10.6. Key Developments

14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
14.3. RESEARCH METHODOLOGY
The List of Companies

1. Medtronic
2. Abbott
3. Boston Scientific Corporation
4. BIOTRONIK
5. LivaNova PLC
6. Merit Medical Systems
7. NIHON KOHDEN CORPORATION
8. Koninklijke Philips N.V.
9. Lepu Medical Technology Co. Ltd.
10. Japan Lifeline Co., Ltd.

Select License Type
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book